| Literature DB >> 26531161 |
Chiung-Yao Huang1, Ping-Jyun Sung2,3, Chokkalingam Uvarani1,2, Jui-Hsin Su2,3, Mei-Chin Lu2,3, Tsong-Long Hwang4, Chang-Feng Dai5, Shwu-Li Wu6, Jyh-Horng Sheu1,7,8.
Abstract
Glaucumolides A (1) and B (2), novel biscembranes composed of an unprecedented α,β-unsaturated ε-lactone, along with the known metabolites ximaolide A (3) and isosarcophytonolide D (4), were isolated from the cultured soft coral Sarcophyton glaucum. The structures of the new metabolites were determined by extensive spectroscopic analyses. Compounds 1 and 2 were shown to exhibit cytotoxicity against a limited panel of cancer cell lines. In anti-inflammation assay, compounds 1 and 2 displayed strong inhibition of superoxide anion generation and elastase release in human neutrophils stimulated by fMLP/CB. Furthermore, both 1 and 2 were shown to significantly inhibit the accumulation of the pro-inflammatory inducible nitric oxide synthase protein, and compounds 1-3 were found to effectively reduce the expression of cyclooxygenase-2 protein, in lipopolysaccharide-stimulated RAW264.7 macrophage cells.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26531161 PMCID: PMC4632109 DOI: 10.1038/srep15624
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1The cultured soft coral Sarcophyton glaucum.
Figure 2Chemical structures of metabolites 1–4.
1H and 13C NMR Data of 1 and 2.
| Position | 1 | 2 | ||
|---|---|---|---|---|
| 1H | 13C | 1H | 13C | |
| 1 | 53.3 (C) | 52.9 (C) | ||
| 2 | 2.33 m | 41.5 (CH) | 1.87 m | 41.4 (CH) |
| 3 | 3.95 dd (11.2, 6.0) | 84.4 (CH) | 4.01 dd (11.2, 5.6) | 85.5 (CH) |
| 4 | 1.50 d (10.8) | 48.7 (CH) | 1.85 m | 47.3 (CH) |
| 5 | 4.82 dd (11.2, 3.2) | 73.1 (CH) | 4.82 dd (11.2, 3.2) | 71.9 (CH) |
| 6 | 2.28 m; 2.24 m | 41.0 (CH2) | 2.26 m; 2.18 m | 41.7 (CH2) |
| 7 | 132.5 (C) | 131.7 (C) | ||
| 8 | 5.14 dd (6.4, 6.4) | 127.2 (CH) | 5.17 dd (7.6, 7.6) | 127.9 (CH) |
| 9 | 2.32 m | 24.7 (CH2) | 2.29 m; 2.21 m | 25.1 (CH2) |
| 10 | 2.31 m; 2.25 m | 40.6 (CH2) | 3.00 m | 31.2 (CH2) |
| 11 | 161.1 (C) | 162.7 (C) | ||
| 12 | 5.78 s | 125.0 (CH) | 5.98 s | 124.6 (CH) |
| 13 | 197.4 (C) | 198.1 (C) | ||
| 14 | 2.79 d (13.2); 2.46 d (13.2) | 50.7 (CH2) | 2.99 m; 2.37 m | 52.4 (CH2) |
| 15 | 2.20 m | 25.7 (CH) | 2.17 m | 25.6 (CH) |
| 16 | 1.08 d (6.8) | 18.2 (CH3) | 1.08 d (6.8) | 18.4 (CH3) |
| 17 | 1.10 d (6.8) | 25.1 (CH3) | 1.17 d (6.8) | 25.0 (CH3) |
| 18 | 1.65 s | 17.9 (CH3) | 1.65 s | 17.1 (CH3) |
| 19 | 2.12 s | 19.6 (CH3) | 1.89 s | 24.8 (CH3) |
| 20 | 177.9 (C) | 179.1 (C) | ||
| 21 | 3.05 d (10.0) | 45.5 (CH) | 2.96 m | 45.1 (CH) |
| 22 | 5.11 d (10.0) | 123.0 (CH) | 4.94 d (10.8) | 122.8 (CH) |
| 23 | 138.7 (C) | 138.3 (C) | ||
| 24 | 2.12 m; 2.08 m | 36.2 (CH2) | 2.14 m; 2.02 m | 36.4 (CH2) |
| 25 | 1.82 m; 1.36 m | 29.1 (CH2) | 1.84 m; 1.31 m | 29.2 (CH2) |
| 26 | 4.16 dd (7.6, 7.6) | 68.3 (CH) | 4.16 dd (7.6, 7.6) | 67.8 (CH) |
| 27 | 82.9 (C) | 82.6 (C) | ||
| 28 | 2.18 m; 2.04 m | 34.8 (CH2) | 2.20 m; 2.04 m | 34.6 (CH2) |
| 29 | 2.46 m | 26.2 (CH2) | 2.47 m | 26.6 (CH2) |
| 30 | 5.93 br s | 135.1 (CH) | 5.89 br s | 135.4 (CH) |
| 31 | 132.8 (C) | ND | ||
| 32 | 2.58 m; 2.18 m | 30.0 (CH2) | 2.65 m; 2.35 m | 30.1 (CH2) |
| 33 | 2.66 m; 2.16 m | 29.1 (CH2) | 2.79 m; 2.07 m | 29.3 (CH2) |
| 34 | 132.1 (C) | 131.3 (C) | ||
| 35 | 127.4 (C) | 127.4 (C) | ||
| 36 | 2.31 m; 2.04 m | 34.8 (CH2) | 2.31 m; 2.10 m | 35.3 (CH2) |
| 37 | 1.81 s | 20.2 (CH3) | 1.81 s | 20.3 (CH3) |
| 38 | 1.62 s | 16.0 (CH3) | 1.60 s | 15.9 (CH3) |
| 39 | 1.32 s | 22.0 (CH3) | 1.31 s | 21.8 (CH3) |
| 40 | 168.9 (C) | 168.5 (C) | ||
| 41 | 2.13 s | 21.5 (CH3) | 2.11 s | 21.5 (CH3) |
| 42 | 170.5 (C) | 170.6 (C) | ||
aRecorded at 400 MHz in CDCl3 at 25 °C.
bRecorded at 100 MHz in CDCl3 at 25 °C.
cJ values (Hz) in parentheses.
dAttached protons were deduced by DEPT experiment.
eDesignate signal not detected17.
Figure 3Selected COSY () and HMBC (→) correlations of 1 and 2.
Figure 4Selected NOE correlations for 1.
Figure 5CD spectrum (1.2 × 10−4 M, MeOH) of 2.
Cytotoxicity of compounds 1–4.
| cancer cell line | Compounds (ED50, | ||||
|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5-Fluorouracil | |
| HL-60 | 6.6 ± 1.2 | 3.8 ± 0.9 | – | 13.0 ± 1.9 | 10.7 ± 0.5 |
| CCRF-CEM | 7.4 ± 1.5 | 5.3 ± 1.4 | – | 15.3 ± 2.5 | 2.3 ± 0.6 |
| MOLT-4 | 11.0 ± 2.8 | 11.0 ± 2.2 | – | 17.2 ± 3.1 | 0.9 ± 0.2 |
| K-562 | 19.2 ± 2.3 | 12.6 ± 0.7 | – | – | 4.3 ± 1.2 |
The values are mean ± SEM (n = 3).
a>20 μg/mL
Inhibitory effects of compounds 1–4 on superoxide anion generation and elastase release by human neutrophils.
| Compound | Superoxide anion | Elastase release | ||||
|---|---|---|---|---|---|---|
| IC50 (μM) | Inh % | IC50 (μM) | Inh % | |||
| 1 | 2.79 ± 0.66 | 88.42 ± 3.97 | *** | 3.97 ± 0.10 | 88.94 ± 6.96 | *** |
| 2 | 2.79 ± 0.32 | 91.75 ± 3.08 | *** | 3.97 ± 0.10 | 103.25 ± 1.89 | *** |
| 3 | >10 | 15.33 ± 4.15 | * | >10 | 15.13 ± 3.58 | * |
| 4 | >10 | 12.40 ± 2.56 | ** | >10 | 27.12 ± 3.08 | *** |
| Idelalisib | 0.07 ± 0.01 | 102.81 ± 2.21 | *** | 0.28 ± 0.09 | 99.56 ± 4.19 | *** |
aPercentage of inhibition (Inh %) at 10 μM concentration. Results are presented as mean ± S.E.M. (n = 3). *P < 0.05, **P < 0.01, ***P < 0.001 compared with the control value.
bConcentration necessary for 50% inhibition (IC50).
Figure 7Effect of compounds 1–3 on iNOS and COX-2 protein expression of RAW264.7 macrophage cells by immunoblot analysis.
(A) Immunoblots of iNOS and β-actin; (B) Immunoblots of COX-2 and β-actin. The values are mean ± SEM (n = 3). Relative intensity of the LPS alone stimulated group was taken as 100%. Under the same experimental condition CAPE (caffeic acid phenylethyl ester, 10 μM) reduced the levels of the iNOS and COX-2 to 2.5 ± 3.7% and 50.3 ± 8.7%, respectively. *Significantly different from LPS alone stimulated group (*p < 0.05). Stimulated with LPS. Stimulated with LPS in the presence of 1–3 (20 μM). Stimulated with LPS in the presence of 1–3 (10 μM). Stimulate with LPS in the presence of 1–3 (5 μM).